Safety and efficacy of intracranial radiotherapy under immunotherapy against CNS metastases of extensive-stage small cell lung cancer in the real-world setting.
Not Applicable
Recruiting
- Conditions
- ung Cancer
- Registration Number
- JPRN-UMIN000041879
- Lead Sponsor
- Osaka International Cancer Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) The cases which the attending physician has determined ineligible
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety(Grade 3 or higher non-hematological toxicity )
- Secondary Outcome Measures
Name Time Method